pyrindamycin a has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartley, JA; Hudson, S; Kiakos, K; Lee, M; Lingerfelt, B; Purnell, B; Scott, A; Summerville, K; Townes, H | 1 |
| Searcey, M | 1 |
| Inouye, S; Ishii, S; Kariya, Y; Kondo, S; Nagasawa, M; Yamamoto, H | 1 |
1 review(s) available for pyrindamycin a and Leukemia L 1210
| Article | Year |
|---|---|
Duocarmycins--natures prodrugs?
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Cell Survival; DNA; Drug Stability; Duocarmycins; Indoles; Leucomycins; Leukemia L1210; Prodrugs; Pyrroles; Pyrrolidinones; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
2 other study(ies) available for pyrindamycin a and Leukemia L 1210
| Article | Year |
|---|---|
Novel (S)-(-)- and R-(+)-seco-iso-cyclopropylfurano[e]indoline-5,6,7-trimethoxyindole-2-carboxamide (iso-CFI) analogs of duocarmycin C2: synthesis and biological evaluation.
Topics: Animals; Antineoplastic Agents, Alkylating; Base Sequence; Cell Proliferation; DNA; Drug Screening Assays, Antitumor; Duocarmycins; Heterocyclic Compounds, 3-Ring; Indoles; Leukemia L1210; Melanoma, Experimental; Mice; Models, Chemical; Pyrroles; Stereoisomerism; Tumor Cells, Cultured | 2006 |
Antitumor activity of pyrindamycins A and B.
Topics: Animals; Antibiotics, Antineoplastic; DNA, Neoplasm; Duocarmycins; Humans; Indoles; Leukemia L1210; Leukemia P388; Male; Mice; Molecular Structure; Neoplasm Proteins; Pyrroles; RNA, Neoplasm; Specific Pathogen-Free Organisms; Tumor Cells, Cultured | 1989 |